Aquaculture round-up
New vaccine for long-lasting protection against mortality and disease due to streptococcis in fish introduced in Latin America
A
by MSD Animal Health, UK
new vaccine to protect against streptococcosis in fish is now available in Latin America. AQUAVAC® Strep Sa-Si is indicated for the active immunisation of tilapia (Oreochromis sp.) and other susceptible fish species to reduce mortality and disease due to streptococcosis caused by Streptococcus agalactiae (serotype Ib) and Streptococcus iniae. MSD Animal Health recently announced that AQUAVAC® Strep Sa-Si was first launched in Honduras and will be available throughout the Latin America region following local country regulatory approvals. As global tilapia production continues to increase to meet the growing demand for safe and affordable protein that helps contribute to a nutritious diet, disease prevention is fundamental for its sustainability.
estimates that about one billion people worldwide rely on fish as their primary source of animal protein. High in protein and containing many essential micronutrients, fish is critically important to balancing the needs of feeding the growing global population, and meeting the demand for healthy and sustainable protein production. Fish provides more than 4.5 billion people with at least 15 percent of their average per capita intake of animal protein. More than just a source of protein, the unique nutritional properties of fish make it essential to the health of billions of people in developed and developing countries. Fish contains essential amino acids: lysine and methionine, micronutrients: vitamins D, A and B, and minerals: calcium, phosphorus, iodine, zinc, iron and selenium, which makes it particularly important to help alleviate malnutrition in fooddeficient countries.
Population growth continues to drive demand for nutritious, sustainable sources of protein
Streptococcosis is a neurological bacterial disease that affects warm water fish in both salt or freshwater environments, typically in tropical regions. The predominant streptococcal diseases in tilapia are Streptococcus agalactiae and Streptococcus iniae. External clinical signs of streptococcosis include marked hemorrhages, cornea opacity, spinning near the water surface,
By 2050, it is estimated that the world’s population will increase by 34 percent to 9.1 billion people – doubling the demand for global food production, including fish protein. The Food and Agriculture Organisation (FAO) of the United Nations also
Streptococcosis causes widespread morbidity and mortality in warm water fish and significant economic loss for producers
22 | March 2020 - International Aquafeed